Proxy Results Form 8 K

Item 5.07. Submission of Matters to a Vote of Security Holders.

On September 24, 2024, Glucotrack, Inc., (the "Company") held a special meeting of its stockholders (the "Special Meeting"). As of August 19, 2024, the record date for the Special Meeting, there were 5,478,436 shares of the Company's common stock, par value $0.001 per share (the "common stock") issued and outstanding, entitled to 5,478,436 votes in the aggregate. Of the 5,478,436 votes that were eligible to be cast by the holders of common stock at the Special Meeting, 2,360,528 votes, or approximately 43.08% of the total, were represented at the meeting in person or by proxy, constituting a quorum. The proposals listed below are described in more detail in the Company's definitive proxy statement, which was filed with the Securities and Exchange Commission on August 19, 2024 (the "Proxy Statement") Capitalized terms not defined herein shall have the meanings ascribed to them in the Proxy Statement. A summary of the proposals presented to and considered by the stockholders of the Company and the voting results at the Special Meeting are set forth below:

The Issuance Proposal - To approve, for purposes of complying with Nasdaq Listing Rule 5635(b), the full issuance of shares of common stock issuable by the Company upon conversion of the Note issued on July 30, 2024 and exercise of the Warrants issued on July 30, 2024 (the "Issuance Proposal"). The votes regarding this proposal were as follows:

The Adjournment Proposal - To adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if it is determined by the Company that more time is necessary or appropriate to approve the Issuance Proposal at the Special Meeting (the "Adjournment Proposal"). The Adjournment Proposal was not presented at the Special Meeting since the Issuance Proposal received sufficient favorable votes to be adopted.